Colorectal Cancer

I was diagnosed with cancer five years ago, and am extremely grateful for the people I met along the way.

The drug combination of Lonsurf plus Avastin improved survival in patients with pretreated, metastatic, refractory colorectal cancer, according to recently published study findings.

A team from Rutgers University has figured out the science behind once-dormant, self-reviving cells, and the discovery may help predict which patients will experience relapse.

The FDA granted a priority review to Lonsurf with or without Avastin for the treatment of patients with pretreated metastatic colorectal cancer.

The Food and Drug Administration granted botensilimab plus balstilimab a Fast Track Designation to treat certain patients with metastatic colorectal cancer.

Patients with stage 3 colon cancer who reported physical activity after surgical resection may derive a survival benefit and may prolong disease recurrence.

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

Nowadays, I think of myself more as a cancer survivor and advocate than patient. Here's what I learned along the way.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

I’ve had three colonoscopies within five years and am still colorectal cancer-free.

When I was in the throes of cancer, I didn't know how to answer well-meaning people who asked, "How you doin'?"

I’ve had many colonoscopies over the last two decades, so here are my tips for preparing for and going through the procedure.

Hodgkin lymphoma survivors should avoid associated risk factors of developing colorectal cancer such as smoking, alcohol usage and being overweight.

After I was diagnosed with colorectal cancer and told I needed a colectomy, I knew I’d face physical and financial difficulties after the surgery, but I did not anticipate the emotional toll of my diagnosis.

The best of humanity met me at the worst time of my life when I found “my people” after receiving a stage 4 colorectal cancer diagnosis.

Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.

In 2023, my goal is to continue building my role as a patient advocate and to support other cancer survivors in the fight through the various organizations I am involved with.

The PRESERVE 1 trial was discontinued due to responses and survival measures favoring placebo versus Cosela when added to a chemoimmunotherapy regimen.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.

Many men — my former self included — can be stubborn when it comes to cancer screenings or visiting the doctor. Thankfully I’ve changed my ways, which saved my life.

Patients with refractory metastatic colorectal cancer often don’t have many effective treatment options, although immunotherapy may be a promising potential for patients based on recent study findings.

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

The FDA recently approved a combination treatment for patients with previously treated metastatic colorectal cancer with HER2-positive disease determined by biomarker testing.

I recently met another woman with Lynch syndrome, the same hereditary cancer syndrome that I have, and it made me reflect on the steps I was taking to maintain my health.

The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.

The FDA approved Tukysa plus Herceptin for previously treated patients with HER2-positive metastatic colorectal cancer.

The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.

A test that measures tumor DNA in the blood could be a helpful prognostic factor in patients with colorectal cancer who underwent surgery.

Treatments before surgery for rectal adenocarcinoma, a type of rectal cancer, have increased and correlated with preservative surgeries and improved overall survival in the last 16 years, though improvements may still be needed for disease screening, an expert said.